Subscribe To
Sale of walgreen's boots in flux in uk with less bidders, market upset
The multibillion-pound sale of U.K. drugstore Boots has been derailed after a possible buyer walked away and several bidders raised concerns about fin...
March 1, 2022, 11:50 pm
Sale of walgreen's boots in flux in uk with less bidders, market upset
The multibillion-pound sale of U.K. drugstore Boots has been derailed after a possible buyer walked away and several bidders raised concerns about fin...
March 1, 2022, 11:50 pm
5 short squeeze candidates to watch: kaival brands cost to borrow hits record 409%, blink charging and weber grills move up
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...
February 28, 2022, 9:26 am
5 short squeeze candidates to watch: kaival brands cost to borrow hits record 409%, blink charging and weber grills move up
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...
February 28, 2022, 9:26 am
5 short squeeze candidates to watch: kaival brands cost to borrow hits record 409%, blink charging and weber grills move up
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...
February 28, 2022, 9:26 am
Ocugen's stock jumps 4% after saying fda lifted hold on trial for experimental covid-19 shot
Shares of Ocugen Inc. OCGN, -2.40% gained 4.7% in premarket trading on Friday after the company said the Food and Drug Administration lifted the clini...
February 25, 2022, 7:51 am
Ocugen's stock jumps 4% after saying fda lifted hold on trial for experimental covid-19 shot
Shares of Ocugen Inc. OCGN, -2.40% gained 4.7% in premarket trading on Friday after the company said the Food and Drug Administration lifted the clini...
February 25, 2022, 7:51 am
Ocugen's stock jumps 4% after saying fda lifted hold on trial for experimental covid-19 shot
Shares of Ocugen Inc. OCGN, -2.40% gained 4.7% in premarket trading on Friday after the company said the Food and Drug Administration lifted the clini...
February 25, 2022, 7:51 am
Relmada aces rel-1017 vs ketamine study for abuse potential
Relmada Therapeutics Inc (NASDAQ: RLMD) has announced topline results of the human abuse potential (HAP) study with REL-1017 for major depressive d...
February 23, 2022, 11:42 am
Relmada aces rel-1017 vs ketamine study for abuse potential
Relmada Therapeutics Inc (NASDAQ: RLMD) has announced topline results of the human abuse potential (HAP) study with REL-1017 for major depressive d...
February 23, 2022, 11:42 am
Relmada aces rel-1017 vs ketamine study for abuse potential
Relmada Therapeutics Inc (NASDAQ: RLMD) has announced topline results of the human abuse potential (HAP) study with REL-1017 for major depressive d...
February 23, 2022, 11:42 am
Pharmadrug announces positive results from dmt-analogue program to treat glaucoma
PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue ...
February 23, 2022, 9:10 am
Pharmadrug announces positive results from dmt-analogue program to treat glaucoma
PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue ...
February 23, 2022, 9:10 am
Pharmadrug announces positive results from dmt-analogue program to treat glaucoma
PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue ...
February 23, 2022, 9:10 am
Algernon pharmaceuticals begins manufacturing repirinast and launches new chronic kidney disease research program
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) revealed that it has awarded a contract to China's Zhejiang Ausun Pharmaceutical Company Limited ...
February 23, 2022, 9:10 am
Algernon pharmaceuticals begins manufacturing repirinast and launches new chronic kidney disease research program
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) revealed that it has awarded a contract to China's Zhejiang Ausun Pharmaceutical Company Limited ...
February 23, 2022, 9:10 am
Algernon pharmaceuticals begins manufacturing repirinast and launches new chronic kidney disease research program
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) revealed that it has awarded a contract to China's Zhejiang Ausun Pharmaceutical Company Limited ...
February 23, 2022, 9:10 am
Okyo pharma receives us patent for dry eye disease drug covering neuropathic pain
OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101. Th...
February 23, 2022, 2:30 am
Okyo pharma receives us patent for dry eye disease drug covering neuropathic pain
OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101. Th...
February 23, 2022, 2:30 am
Okyo pharma receives us patent for dry eye disease drug covering neuropathic pain
OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101. Th...
February 23, 2022, 2:30 am